The 6:1 diet for the reduction of risk of breast cancer
Testing the feasibility of a 6:1 intermittent diet breast cancer risk reduction programme to promote healthy eating and prevent weight gain in women at increased risk of breast cancer
- Hospital – Speciality: Wythenshawe- Breast Cancer Prevention
- Study type: Interventional
- Funder: Manchester Biomedical Research Centre
Summary
Weight gain in young women increases risk of breast cancer and other cancers and conditions. Weight gain occurs in young women attending high risk clinics and there is an unmet need for effective weight gain prevention interventions for these women. This 4 month feasibility study will test whether a 6:1 intermittent diet is acceptable and can promote healthy eating and limit weight gain with minimal harms in women at increased risk of breast cancer.
Participant group
Women aged 18-40 at increased risk of breast cancer who are a healthy weight.
Participant approach
Potential participants will be invited by health care professionals during consultations or by post. The study will be advertised via a poster displayed in clinics or promoted in the Prevent Cancer website and social media platforms.
Study open date and expected length
Opened: 13 February 2025
Expected end date: 13 February 2026
Results
Pending – this study is still active.
Contact details
Email address: 61.diet@mft.nhs.uk
Telephone number: 0161 291 5815
IRAS number: 343256
